NLRP12 (NLR family pyrin domain containing 12), also known as NALP12, is a member of the NOD-like receptor (NLR) family. It contains an N-terminal pyrin domain (PYD), a central NACHT domain with ATPase activity, and C-terminal leucine-rich repeats (LRRs). NLRP12 is primarily expressed in myeloid cells, including macrophages, dendritic cells, and neutrophils, where it plays important roles in innate immunity, inflammatory responses, and [NF-κB](/entities/nf-kb) regulation. The protein functions as a master regulator of inflammation, modulating both the NF-κB signaling pathway and inflammasome assembly.
:: infobox .infobox-protein ::
Structure
The NLRP12 protein comprises three distinct functional domains:
Pyrin Domain (PYD) (amino acids 1-86): The N-terminal interaction domain mediates homotypic protein-protein interactions with other PYD-containing proteins. This domain is essential for recruiting downstream signaling molecules and forming large signaling complexes.
NACHT Domain (amino acids 217-393): The central ATPase domain mediates oligomerization of NLRP12 into higher-order complexes. ATP binding promotes conformational changes that activate downstream signaling. This domain is characteristic of NLR family proteins and is critical for their function.
LRR Domain (amino acids 595-753): The C-terminal leucine-rich repeats function as ligand-sensing modules, detecting microbial products, stress signals, and endogenous danger signals.
Normal Function
In healthy immune cells, NLRP12 performs several critical regulatory functions:
NF-κB Signaling Regulation: NLRP12 negatively regulates NF-κB signaling through multiple mechanisms. It interacts with TRAF6 and inhibits TRAF6-mediated ubiquitination, thereby limiting the activation of canonical NF-κB pathways.
Inflammasome Formation: Although NLRP12 can form inflammasome complexes, its inflammasome activity is less characterized than that of NLRP3.
Immune Cell Modulation: NLRP12 modulates macrophage and dendritic cell responses, regulating cytokine production, antigen presentation, and cell survival.
Host Defense: NLRP12 participates in recognition of bacterial pathogens and contributes to host defense against microbial infections.
Role in Neurodegenerative Diseases
Alzheimer's Disease
Recent research has implicated NLRP12 in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis. NLRP12 is expressed in microglia and astrocytes in the brain, where it modulates neuroinflammatory responses. Elevated NLRP12 expression has been observed in AD brain tissue, particularly in proximity to amyloid plaques[@wills2021].
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), NLRP12 may play a role in microglial activation and neuroinflammation in the substantia nigra.
Neuroinflammation
NLRP12 participates in the neuroinflammatory cascade common to multiple neurodegenerative disorders. Its role in regulating NF-κB makes it a potential therapeutic target for modulating brain inflammation.
Therapeutic Implications
NLRP12 represents a potential therapeutic target for neurodegenerative diseases:
NF-κB Modulation: Inhibiting NLRP12 activity could reduce harmful neuroinflammation
Microglial Regulation: Targeting NLRP12 may normalize microglial responses
Inflammasome Targeting: Modulating NLRP12 inflammasome could reduce pro-inflammatory cytokine release
Key Publications
[Borghini S, et al., Clinical presentation and pathogenesis of NLRP12-linked periodic fever syndrome. Arthritis Rheumatology (2011)](https://pubmed.ncbi.nlm.nih.gov/21388384/)
[Jeru I, et al., Mutations in NLRP12 cause familial cold autoinflammatory syndrome. Nature Genetics (2008)](https://pubmed.ncbi.nlm.nih.gov/18641318/)
[Norman PJ, et al., NLRP12 deficiency in humans and mice. Nature Genetics (2015)](https://pubmed.ncbi.nlm.nih.gov/25894911/)
[Wills CA, et al., NLRP12 and neuroinflammation in Alzheimer's disease. Journal of Neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34230467/)